Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission
Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
Hepatitis B virus epidemiology
JH MacLachlan, BC Cowie - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
The epidemiology of hepatitis B virus (HBV) infection is geographically diverse, with
population prevalence, age and mode of acquisition, and likelihood of progression to …
population prevalence, age and mode of acquisition, and likelihood of progression to …
[PDF][PDF] Dual programmed death receptor‐1 and vascular endothelial growth factor receptor‐2 blockade promotes vascular normalization and enhances antitumor …
Background and Aims Activation of the antitumor immune response using programmed
death receptor‐1 (PD‐1) blockade showed benefit only in a fraction of patients with …
death receptor‐1 (PD‐1) blockade showed benefit only in a fraction of patients with …
Global epidemiology of hepatitis B virus infection
D Lavanchy, M Kane - Hepatitis B virus in human diseases, 2016 - Springer
Hepatitis B is one of the major diseases of mankind, estimated to cause about 800,000
deaths per year mostly from liver cancer and cirrhosis. The history of the epidemiology of …
deaths per year mostly from liver cancer and cirrhosis. The history of the epidemiology of …
Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease
Objective People with chronic liver disease, particularly those with decompensated cirrhosis,
experience several potentially debilitating complications that can have a significant impact …
experience several potentially debilitating complications that can have a significant impact …
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health …
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity
and mortality due to liver failure and hepatocellular carcinoma (HCC). More than 248 million …
and mortality due to liver failure and hepatocellular carcinoma (HCC). More than 248 million …
Estimating the global prevalence of hepatitis B
JH MacLachlan, S Locarnini, BC Cowie - The Lancet, 2015 - thelancet.com
Estimating the global prevalence of hepatitis B - The Lancet Skip to Main Content
Advertisement The Lancet Journal This Journal Back Journal Home Online First Current Issue …
Advertisement The Lancet Journal This Journal Back Journal Home Online First Current Issue …
[PDF][PDF] Modeling progress toward elimination of hepatitis B in Australia
Background and Aims Chronic hepatitis B (CHB) is a significant global health concern, and
the most prevalent blood‐borne virus in Australia. World Health Organization (WHO) …
the most prevalent blood‐borne virus in Australia. World Health Organization (WHO) …
[HTML][HTML] Hepatitis B knowledge and associated factors among people with chronic hepatitis B
Objective: To assess hepatitis B knowledge among people with chronic hepatitis B (CHB) in
Australia. Methods: People with CHB in three Australian jurisdictions completed a self …
Australia. Methods: People with CHB in three Australian jurisdictions completed a self …
[HTML][HTML] The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment
Objective: To estimate the level of access to diagnosis, management and treatment for
people living with chronic hepatitis B (CHB) in Australia, and to identify the gaps in clinical …
people living with chronic hepatitis B (CHB) in Australia, and to identify the gaps in clinical …